MedTrace Logo

Prevention of Inappropriate Therapies and MACCE With a Single Chamber ICD With DX Floating Dipole Atrial Detection

NCT04344704 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2020-04-14

No results posted yet for this study

Summary

Prevention of inappropriate therapies and serious adverse cardiac and cerebrovascular events with a single chamber implantable defibrillator with DX floating dipole atrial detection

Conditions

  • Prevention of Inappropriate Therapies and MACCE. Single-chamber ICD

Interventions

OTHER

Single chamber DAI device with floating atrial dipole

DAI for the detection of atrial signals with optimized programming, using Smart, Onset \& Stability, and Morphmatch methods

Sponsors & Collaborators

  • Trialance SCCL

    lead INDUSTRY

Principal Investigators

  • Ignacio Fernández Lozano, MD · Hospital Universitario Puerta de Hierro (HUPH)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-02
Primary Completion
2022-09-30
Completion
2023-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04344704 on ClinicalTrials.gov